AMPKα2 Overexpression Reduces Cardiomyocyte Ischemia-Reperfusion Injury Through Normalization of Mitochondrial Dynamics

Yuanyan Deng,Sainan Chen,Mingming Zhang,Chen Li,Jing He,Ying Tan

DOI: https://doi.org/10.3389/fcell.2020.00833

IF: 5.5

2020-08-27

Frontiers in Cell and Developmental Biology

Abstract:Cardiac ischemia-reperfusion (I/R) injury is associated with mitochondrial dysfunction. Recent studies have reported that mitochondrial function is determined by mitochondrial dynamics. Here, we hypothesized that AMPKα2 functions as an upstream mediator that sustains mitochondrial dynamics in cardiac I/R injury and cardiomyocyte hypoxia-reoxygenation (H/R) <i>in vitro</i>. To test this, we analyzed cardiomyocyte viability and survival along with mitochondrial dynamics and function using western blots, qPCR, immunofluorescence, and ELISA. Our results indicated that both AMPKα2 transcription and translation were reduced by H/R injury in cardiomyocytes. Decreased AMPKα2 levels were associated with cardiomyocyte dysfunction and apoptosis. Adenovirus-mediated AMPKα2 overexpression dramatically inhibited H/R-mediated cardiomyocyte damage, possibly by increasing mitochondrial membrane potential, inhibiting cardiomyocyte oxidative stress, attenuating intracellular calcium overload, and inhibiting mitochondrial apoptosis. At the molecular level, AMPKα2 overexpression alleviated abnormal mitochondrial division and improved mitochondrial fusion through activation of the Sirt3/PGC1α pathway. This suggests AMPKα2 contributes to maintaining normal mitochondrial dynamics. Indeed, induction of mitochondrial dynamics disorder abolished the cardioprotective effects afforded by AMPKα2 overexpression. Thus, cardiac I/R-related mitochondrial dynamics disorder can be reversed by AMPKα2 overexpression in a manner dependent on the activation of Sirt3/PGC1α signaling.

cell biology,developmental biology

What problem does this paper attempt to address?

This paper attempts to solve the problem of mitochondrial dysfunction in myocardial ischemia - reperfusion (I/R) injury. Specifically, the authors hypothesized that AMPK α2, as an upstream mediator, maintains mitochondrial homeostasis in cardiac I/R injury and in vitro cardiomyocyte hypoxia/reoxygenation (H/R). By analyzing the survival rate of cardiomyocytes, mitochondrial dynamics and function, the study found that over - expression of AMPK α2 can significantly inhibit cell damage caused by H/R, which may be achieved by increasing mitochondrial membrane potential, suppressing oxidative stress, alleviating intracellular calcium overload and inhibiting mitochondrial apoptosis. In addition, over - expression of AMPK α2 can also improve abnormal mitochondrial fission and promote mitochondrial fusion by activating the Sirt3/PGC1 α signaling pathway, thereby maintaining normal mitochondrial homeostasis. The study also showed that inducing mitochondrial dynamic imbalance can eliminate the protective effect brought by over - expression of AMPK α2, further confirming the important role of AMPK α2 in cardiac I/R - related mitochondrial dynamic imbalance.